SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic. 

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

New research, presented during ACC.23/WCC in New Orleans, has raised fresh concerns about the potential cardiovascular-related drawbacks of high-fat, low-carbohydrate diets. 

Hundreds of physicians participated in the strike, which included a boycott of all outpatient services. The attacked cardiologist was left with a broken nose and missing teeth.

The veteran interventional cardiologist told Cardiovascular Business he sees potential in the ACC's ability to grow both nationally and internationally in the next year. 

Monthly marijuana use, meanwhile, was not associated with a greater CAD risk. The full study is scheduled to be presented at ACC.23/WCC in New Orleans.

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

According to a new study published in JAMA Network Open, these lies directly contributed to COVID-19 morbidity and mortality. 

Industry giant Abbott estimated that the new test could reduce the number of unnecessary computed tomography scans by up to 40%.